Dr. M. Kotteswaran, Dr. S. Sethupathy, Dr. K. Santha, Dr. A. Mallika


Postmenopausal women are more prone for cardiovascular disease due to decreased or complete absence of endogenous estrogen hormone. Cardiovascular disease (CVD) is the leading global cause of death, in that 49% of them are female population. The risk of CVD increases sharply after menopause and the exact underlying mechanism for association of post menopause with cardiovascular disease needs to be evaluated. So, we analyzed serum hsCRP, an inflammatory marker and  lipid peroxidation levels in 55 Post-menopausal women in the age group of 45 to 55 years (obese: n=30 and non-obese: n=25) with no history of cardiac and other chronic disorders. Ethical clearance and written consent were obtained. hs-CRP was assayed by ELISA method and lipid peroxidation as thiobarbituric acid reactive substances (TBARS) was estimated using spectrophotometer. High sensitivity C - reactive protein (hs-CRP) and TBARS were found to be significantly elevated in obese post-menopausal women than in non- obese (p<0.05). There was significant positive correlation between hs-CRP and TBARS (p<0.01) in post-menopausal women. It is concluded that elevated oxidative stress and inflammation could increase the risk for CVD in obese postmenopausal women.



Post-menopausal women, hsCRP, Lipid peroxidation,CVD.

Full Text:



Benjamin EJ et. a. 2019. Heart Disease and Stroke Statistics-2019 At-a-Glance Heart Disease, Stroke and other Cardiovascular Diseases. 2019; Available from: https://professional.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_503396.pdf

Abdulnour J, Doucet É, Brochu M, Lavoie JM, Strychar I, Rabasa-Lhoret R, et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: A Montreal-Ottawa New Emerging Team group study. Menopause. 2012;19(7):760–7.

Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2009;204(1):255–61.

Pappa T, Alevizaki M. Endogenous sex steroids and cardio- and cerebro-vascular disease in the postmenopausal period. Eur J Endocrinol. 2012;167(2):145–56.

El Khoudary SR, Wildman RP, Matthews K, Thurston RC, Bromberger JT, Sutton-Tyrrell K. Progression rates of carotid intima-media thickness and adventitial diameter during the menopausal transition. Menopause. 2013;20(1):8–14.

Frostegård J. Peripheral Neuropathy and HIV - VA National HIV/AIDS Website. 2013;1–8. Available from: papers3://publication/uuid/D0C88CBA-A315-4DF2-8BF5-CD34F24146B2

Ross R. Cell Biology of Atherosclerosis. Annu Rev Physiol. 1995;57(1):791–804.

Higashi. Endothelial Function in Cardiovascular Diseases. Circ J. 2009;73(March):411–8.

Čejková S, Králová-Lesná I, Poledne R. Monocyte adhesion to the endothelium is an initial stage of atherosclerosis development. Cor Vasa. 2016;58(4):e419–25.

Cells HE, Pasceri V, Willerson JT, Yeh ETH. Direct Proinflammatory Effect of C-Reactive Protein on. 2015;2165–9.

Cells HE, Pasceri V, Willerson JT, Yeh ETH. Direct Proinflammatory Effect of C-Reactive Protein on. Circulation. 2000;2165–8.

Pasceri V, Chang J, Willerson JT, Yeh ETH. Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs. Circulation. 2001;

Fröhlich M, Waltenberger J, Koenig W, Torzewski J, Hombach V, Bowyer DE, et al. C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries. Arterioscler Thromb Vasc Biol. 2011;18(9):1386–92.

Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis. Circulation. 2001;103(9):1194–7.

Aziz N, Kallur SD, Nirmalan P. Implicationsof the revised consensus body mass indices for Asian Indians on clinical obstetric practice. J Clin Diagnostic Res. 2014;8(5):3–5.

Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation. 2003;107(3):499–511.

Sohrabji F, Okoreeh A, Panta A. Sex hormones and stroke: Beyond estrogens. Horm Behav. 2019;111(October):87–95.

Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity & inflammation: The linking mechanism & the complications. Arch Med Sci. 2017;13(4):851–63.

Gökhan S. Hotamisligi. Inflammation and metabolic disorder. Nature. 2006;444.


  • There are currently no refbacks.